- Home
- Chemistry
- Pharmaceutical and Medicinal Chemistry
- Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data
Advances in Clinical Immunology, Medical Microbiology, COVID-19, and Big Data
edited by Raj Bawa
- Format: Hardcover
- ISBN: 9789814877848
- Series: Current Issues in Medicine
- Subject: Pharmaceutical and Medicinal Chemistry
- Published: December 2021
- Pages: 930
USD $379.95
For Course Instructors: Inspection Copies
Retailers:
The pace and sophistication of advances in medicine in the past two decades have necessitated a growing need for a comprehensive reference that highlights current issues in medicine. Each volume in the Current Issues in Medicine series is a stand‐alone text that provides a broad survey of various critical topics—all accomplished in a user-friendly yet interconnected format. The series not only highlights current advances but also explores related topics such as translational medicine, regulatory science, neglected diseases, global pandemics, patent law, immunotoxicology, theranostics, big data, artificial intelligence, novel imaging tools, combination drug products, and novel therapies. While bridging the gap between basic research and clinical medicine, this series provides a thorough understanding of medicine’s potential to address health problems from both the patient’s and the provider’s perspectives in a healthcare setting. The range of topics covered and the expertise of the contributing authors accurately reflect the rapidly evolving areas within medicine—from basic medical sciences to clinical specialties. Each volume is essential reading for physicians, medical students, nurses, fellows, residents, undergraduate and graduate students, educators, policymakers, and biomedical researchers. The multidisciplinary approach of the series makes it a valuable reference resource for the pharmaceutical industry, academia, and governments. However, unlike other series on medicine or medical textbooks, this series focuses on current trends, perspectives, and issues in medicine that are central to healthcare delivery in the 21st century. Volume 2 focuses on the current issues in basic medical sciences, subjects that are fundamental to the practice of medicine. Specifically, it discusses clinical immunology, medical microbiology, COVID-19, and big data. These subjects, traditionally taught in the first two years of medical school that precede clinical instruction, provide a core of basic knowledge critical to the success in clinical medicine during rotations, training, and medical practice.
Download sample chapter:
Chapter 1: SARS-CoV-2 and COVID-19: A Perspective (PDF)
Chapter 33: COVID-19: Hundred Questions and Answers for Healthcare Providers and the Public (PDF)
Chapter 1
SARS-CoV-2 and COVID-19: A Perspective
Raj Bawa, MS, PhD, MD 22
Pages: 1-40
USD $34.95
Add to cartChapter 2
Specific Reactivity of Anti-Citrullinated Protein Antibodies to Citrullinated Peptides Associated with Rheumatoid Arthritis
Nicole H. Trier, PhD, Bettina E. Holm, Paul R. Hansen, PhD, Ole Slot, MD, Henning Locht, MD, and Gunnar Houen, PhD
Pages: 41-54
USD $34.95
Add to cartChapter 3
Complement Activation, Immunogenicity, and Immune Suppression as Potential Side Effects of Liposomes
Janos Szebeni, MD, PhD, DSc, and Yechezkel (Chezy) Barenholz, PhD
Pages: 55-76
USD $34.95
Add to cartChapter 4
Human Clinical Relevance of the Porcine Model of Pseudoallergic Infusion Reactions
János Szebeni, MD, PhD, DSc, and Raj Bawa, MS, PhD, MD 22
Pages: 77-108
USD $34.95
Add to cartChapter 5
Myelin Antigens and Antimyelin Antibodies
Fredrick J. Seil, MD
Pages: 109-126
USD $34.95
Add to cartChapter 6
Advances in the Understanding of the Inflammatory Milieu and Its Correlations with Neurological Disorders
Mario Ganau, MD, PhD, MBA, Sibel E. Huet, MD, Nikolaos Syrmos, MD, PhD, Mohammad Iqbal, MBBS, and Marco Meloni, MD
Pages: 127-136
USD $34.95
Add to cartChapter 7
Role of Ligustrum in Allergic Disease
Priyadharshini Vellore Suresh, PhD, Tania Robledo Retana, PhD, Blessy M. Mani, PhD, Ana Paulina Barba de la Rosa, PhD, and Luis M. Teran, MD, PhD
Pages: 137-150
USD $34.95
Add to cartChapter 8
Protective or Detrimental? The Role of Host Immunity in Leishmaniasis
Camila dos Santos Meira and Lashitew Gedamu, PhD
Pages: 151-186
USD $34.95
Add to cartChapter 9
Personalized Nanomedicines for Treatment of Autoimmune Disease
Cheng Lin, Huihua Ding, MD, Congcong Li, PhD, MD, Nan Shen, PhD, MD, Aimin Zhao, PhD, MD, and Matthias Bartneck, PD, PhD
Pages: 187-206
USD $34.95
Add to cartChapter 10
Intracellular Antibody Immunity and Its Applications
Jingwei Zeng, PhD, and Leo C. James, PhD
Pages: 207-216
USD $34.95
Add to cartChapter 11
Maternal Antibody Interference Contributes to Reduced Rotavirus Vaccine Efficacy in Developing Countries
Claire E. Otero, Stephanie N. Langel, PhD, Maria Blasi, PhD, and Sallie R. Permar, MD, PhD
Pages: 217-230
USD $34.95
Add to cartChapter 12
Reflections on 40 Years of AIDS
Kevin M. De Cock, MD, Harold W. Jaffe, MD, MA, and James W. Curran, MD, MPH
Pages: 231-246
USD $34.95
Add to cartChapter 13
Formation and Maturation of the Oral Microbiota
Luca Fiorillo, DDS, Gabriele Cervino, DDS, PhD, and Marco Cicciù, DDS, MSc, PhD
Pages: 247-254
USD $34.95
Add to cartChapter 14
Could the Environment Affect the Mutation of H1N1 Influenza Virus?
Dong Jiang, PhD, Qian Wang, PhD, Zhihua Bai, PhD, Heyuan Qi, PhD, Juncai Ma, PhD, Wenjun Liu, PhD, Fangyu Ding, PhD, and Jing Li, PhD
Pages: 255-268
USD $34.95
Add to cartChapter 15
Current Perspec
Raj Bawa, MS, PhD, MD 22
Pages: 269-352
USD $34.95
Add to cartChapter 16
Bacterial Virulence Plays a Crucial Role in Methicillin-Resistant S. aureus Sepsis
Gordon Y. C. Cheung, PhD, Justin S. Bae, Ryan Liu, MSc, Rachelle L. Hunt, Yue Zheng, and Michael Otto, PhD
Pages: 353-376
USD $34.95
Add to cartChapter 17
Where Cancer and Bacteria Meet
Alexandra Merlos, PhD, Ricardo Perez-Tomás, PhD, José López-López, PhD, and Miguel Viñas, PhD
Pages: 377-398
USD $34.95
Add to cartChapter 18
Fungal Diseases as Neglected Pathogens: A Wake-Up Call to Public Health Officials
Marcio L. Rodrigues, PhD, and Joshua D. Nosanchuk, MD, PhD
Pages: 399-412
USD $34.95
Add to cartChapter 19
Catch the Wave: Metabolomic Analyses in Human Pathogenic Fungi
Philipp Brandt, Enrico Garbe, and Slavena Vylkova, PhD
Pages: 413-424
USD $34.95
Add to cartChapter 20
The Unmet Medical Need for Trypanosoma cruzi-Infected Patients: Monitoring the Disease Status
Maan Zrein, PhD, and Eric Chatelain, PhD
Pages: 425-434
USD $34.95
Add to cartChapter 21
Present and Future of Carbapenem-Resistant Enterobacteriaceae Infections
Beatriz Suay-García, PhD, and María Teresa Pérez-Gracia, PhD
Pages: 435-456
USD $34.95
Add to cartChapter 22
Human Plague: An Old Scourge That Needs New Answers
Xavier Vallès, PhD, Nils Chr. Stenseth, PhD, Christian Demeure, PhD, Peter Horby, MD, PhD, Paul S. Mead, MD, Oswaldo Cabanillas, PhD, Mahery Ratsitorahina, PhD, Minoarisoa Rajerison, PhD, Voahangy Andrianaivoarimanana, PhD, Beza Ramasindrazana, PhD, Javier Pizarro-Cerda, PhD, Holger C. Scholz, PhD,
Pages: 457-484
USD $34.95
Add to cartChapter 23
Human Brain/Cloud Interface
Nuno R. B. Martins, PhD, Amara Angelica, BGE, Krishnan Chakravarthy, PhD, MD, Yuriy Svidinenko, MS, Frank J. Boehm, Ioan Opris, PhD, Mikhail A. Lebedev, PhD, Melanie Swan, MS, Steven A. Garan, PhD, Jeffrey V. Rosenfeld, PhD, MD, Tad Hogg, PhD, and Robert A. Freitas Jr., JD
Pages: 485-538
USD $34.95
Add to cartChapter 24
Artificial Intelligence in Drug Discovery: What Is New, and What Is Next?
Francesca Lake, PhD
Pages: 539-546
USD $34.95
Add to cartChapter 25
Now the Future, We See Our Dreams: Artificial Intelligence in Drug Discovery
Ray Lawrence, PhD
Pages: 547-552
USD $34.95
Add to cartChapter 26
Big Data and Artificial Intelligence Meet the COVID-19 Pandemic: Potential Applications and Promises
Nicola Luigi Bragazzi, MD, PhD, Haijiang Dai, PhD, Giovanni Damiani, PhD, Masoud Behzadifar, PhD, Mariano Martini, PhD, and Jianhong Wu, PhD
Pages: 553-566
USD $34.95
Add to cartChapter 27
Paradigm Shift in Medicinal Chemistry towards Data-Driven Approaches
Jürgen Bajorath, PhD
Pages: 567-572
USD $34.95
Add to cartChapter 28
The Importance of Proper Statistical Methods in Developing Robust Predictive Models Using Chemodescriptors and Biodescriptors in the Twenty First Century
Subhash C. Basak, PhD
Pages: 573-582
USD $34.95
Add to cartChapter 29
Fit-for-Purpose?—Challenges and Opportunities for Applications of Blockchain Technology in the Future of Healthcare
Tim K. Mackey, PhD, Tsung-Ting Kuo, PhD, Basker Gummadi, MS, Kevin A. Clauson, PhD, George Church, PhD, Dennis Grishin, PhD, Kamal Obbad, Robert Barkovich, PhD, and Maria Palombini, MBA
Pages: 583-610
USD $34.95
Add to cartChapter 30
mHealth Approach to Clinics in Rural Settings in Nutrition Counseling
Melissa D. Olfert, PhD, Makenzie L. Barr, PhD, Rebecca L. Hagedorn, PhD, Dustin M. Long, PhD, Treah S. Haggerty, MD, Mathew Weimer, MD, Joseph Golden, MD, Mary Ann Maurer, DO, Jill D. Cochran, PhD, Tracy Hendershot, MD, Stacey L. Whanger, MD, Jay D. Mason, MD, and Sally L. Hodder, MD
Pages: 611-630
USD $34.95
Add to cartChapter 31
Ten Simple Rules for Engaging with Artificial Intelligence in Biomedicine
Avni Malik, Paranjay Patel, MD, Lubaina Ehsan, MD, Shan Guleria, MD, Thomas Hartka, MD, Sodiq Adewole, and Sana Syed, MD
Pages: 631-646
USD $34.95
Add to cartChapter 32
Five Key Aspects of Metaproteomics as a Tool to Understand Functional Interactions in Host Associated Microbiomes
Fernanda Salvato, PhD, Robert L. Hettich, PhD, and Manuel Kleiner, PhD
Pages: 647-662
USD $34.95
Add to cartChapter 33
COVID-19: Hundred Questions and Answers for Healthcare Providers and the Public
Raj Bawa, MS, PhD, MD 22
Pages: 663-752
USD $34.95
Add to cartChapter 34
SARS-CoV-2 Tropism, Entry, Replication, and Propagation: Considerations for Drug Discovery and Development
Nicholas Murgolo, PhD, Alex G. Therien, PhD, Bonnie Howell, PhD, Daniel Klein, PhD, Kenneth Koeplinger, PhD, Linda A. Lieberman, PhD, Gregory C. Adam, PhD, Jessica Flynn, PhD, Philip McKenna, PhD, Gokul Swaminathan, PhD, Daria J. Hazuda, PhD, and David B. Olsen, PhD
Pages: 753-776
USD $34.95
Add to cartChapter 35
Presence of Antibody-Dependent Cellular Cytotoxicity against SARS-CoV-2 in COVID-19 Plasma
For Yue Tso, Salum J. Lidenge, Lisa K. Poppe, Phoebe B. Peña, Sara R. Privatt, Sydney J. Bennett, John R. Ngowi, Julius Mwaiselage, Michael Belshan, Jacob A. Siedlik, Morgan A. Raine, Juan B. Ochoa, Julia Garcia-Diaz, Bobby Nossaman, Lyndsey Buckner, W. Mark Roberts, Matthew J. Dean, Augusto Ochoa
Pages: 777-790
USD $34.95
Add to cartChapter 36
Performance of SARS-CoV-2 Serology Tests: Are They Good Enough?
Isabelle Piec, PhD, Emma English, Mary Annette Thomas, MPhil, Samir Dervisevic, MD, William D. Fraser, MD, and William Garry John
Pages: 791-808
USD $34.95
Add to cartChapter 37
Forecasting the Novel Coronavirus COVID-19
Fotios Petropoulos, DEng, and Spyros Makridakis, PhD
Pages: 809-820
USD $34.95
Add to cartChapter 38
Pandemic Responses: Planning to Neutralize SARS-CoV-2 and Prepare for Future Outbreaks
The PLOS Medicine Editors
Pages: 821-824
USD $34.95
Add to cartChapter 39
Pandemic Preparedness and Responses: WHO to Turn to in a Crisis?
The PLOS Medicine Editors
Pages: 825-828
USD $34.95
Add to cartChapter 40
Links between Integrin αvβ3 and COVID-19: Impact on Vascular and Thrombotic Risk
Marwa S. Hamza, PhD, and Shaker A. Mousa, PhD, MBA
Pages: 829-838
USD $34.95
Add to cartChapter 41
The Ocular Surface and the Coronavirus Disease 2019: Does a Dual ‘Ocular Route’ Exist?
Pietro Emanuele Napoli, MD, Matteo Nioi, MD, Ernesto d’Aloja, MD, and Maurizio Fossarelo, MD
Pages: 839-846
USD $34.95
Add to cartChapter 42
Exploring Links between Vitamin D Deficiency and COVID-19
Mradul Mohan, MS, PhD, Jerin Jose Cherian, MD, MBA, and Amit Sharma, PhD
Pages: 847-856
USD $34.95
Add to cartChapter 43
Convalescent Serum Therapy for COVID-19: A 19th Century Remedy for a 21st Century Disease
Daniel Montelongo-Jauregui, PhD, Taissa Vila, PhD, Ahmed S. Sultan, BDS, PhD, and Mary Ann Jabra-Rizk, PhD
Pages: 857-868
USD $34.95
Add to cartChapter 44
Preexisting and Inducible Endotoxemia as Crucial Contributors to the Severity of COVID-19 Outcomes
Ilja L. Kruglikov, PhD, Dr Sci, and Philipp E. Scherer, PhD
Pages: 869-876
USD $34.95
Add to cartRaj Bawa, PhD, MD, is president of Bawa Biotech LLC (founded 2002), a biotech/pharma consultancy and patent law firm based in Ashburn, Virginia. Trained as a microbiologist and biochemist, he is an inventor, author, entrepreneur, professor, and registered patent agent (since 2002) licensed to practice before the US Patent & Trademark Office. He is currently scientific advisor to Teva Pharmaceutical Industries, Israel (since 2010); visiting research scholar at Pharmaceutical Research Institute of Albany Pharmacy, Albany, New York; and full professor (adjunct) at NOVA in Annandale, Virginia (since 2004). He is VP/chief IP officer at Guanine, Inc., in Rensselaer, New York (since 2017), a company focused on rapid, accurate detection of infective pathogens. Dr. Bawa has served as a principal investigator of various NCI research grants, and most recently as a principal investigator of a CDC grant to develop an assay for carbapenemase resistant bacteria. Previously, he was an adjunct professor at Rensselaer Polytechnic Institute, Troy, New York, from 1998 to 2018. He held various positions at the US Patent Office, including primary examiner from 1996 to 2002. He earned a BSc (Honors School) in microbiology, MS in cancer biology, PhD in biophysics/biochemistry, and MD. Currently, he is a life member of Sigma Xi, cochair of the nanotech and precision medicine committees of the American Bar Association and founding director of the American Society for Nanomedicine (established 2008). He has authored over 100 publications, edited 10 texts, and serves on the editorial boards of numerous peer-reviewed journals, including serving as an associate editor of Nanomedicine (Elsevier).